NM_001386140.1:c.1783C>T

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001386140.1(MTTP):​c.1783C>T​(p.Arg595*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R595R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

MTTP
NM_001386140.1 stop_gained

Scores

2
3
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 1.41
Variant links:
Genes affected
MTTP (HGNC:7467): (microsomal triglyceride transfer protein) MTP encodes the large subunit of the heterodimeric microsomal triglyceride transfer protein. Protein disulfide isomerase (PDI) completes the heterodimeric microsomal triglyceride transfer protein, which has been shown to play a central role in lipoprotein assembly. Mutations in MTP can cause abetalipoproteinemia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-99611156-C-T is Pathogenic according to our data. Variant chr4-99611156-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 14235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-99611156-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTTPNM_001386140.1 linkc.1783C>T p.Arg595* stop_gained Exon 13 of 18 ENST00000265517.10 NP_001373069.1
MTTPNM_000253.4 linkc.1783C>T p.Arg595* stop_gained Exon 14 of 19 NP_000244.2 P55157-1
MTTPNM_001300785.2 linkc.1534C>T p.Arg512* stop_gained Exon 13 of 18 NP_001287714.2 P55157B7Z7X3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTTPENST00000265517.10 linkc.1783C>T p.Arg595* stop_gained Exon 13 of 18 1 NM_001386140.1 ENSP00000265517.5 P55157-1
MTTPENST00000457717.6 linkc.1783C>T p.Arg595* stop_gained Exon 14 of 19 5 ENSP00000400821.1 P55157-1
MTTPENST00000511045.6 linkc.1534C>T p.Arg512* stop_gained Exon 13 of 18 2 ENSP00000427679.2 E9PBP6
ENSG00000248676ENST00000508578.1 linkn.128+9731G>A intron_variant Intron 2 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151800
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461734
Hom.:
0
Cov.:
33
AF XY:
0.00000413
AC XY:
3
AN XY:
727170
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151800
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74116
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000644
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Abetalipoproteinaemia Pathogenic:4
Mar 28, 2024
Fulgent Genetics, Fulgent Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 25, 2021
Natera, Inc.
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Sep 02, 1993
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Feb 07, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: MTTP c.1783C>T (p.Arg595X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. c.2593G>T (p.Gly865X)). The variant was absent in 251426 control chromosomes (gnomAD) but has been reported in the literature in individuals affected with Abetalipoproteinaemia (e.g. Bassen-Kornzweig Syndrome; Chardon_2009, Ohashi_2000, Sharp_1993). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -

MTTP-related disorder Pathogenic:1
Mar 14, 2023
PreventionGenetics, part of Exact Sciences
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The MTTP c.1783C>T variant is predicted to result in premature protein termination (p.Arg595*). This variant was reported in the homozygous state in an individual with abetalipoproteinaemia (Sharp et al. 1993. PubMed ID: 8361539). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in MTTP are expected to be pathogenic. This variant is interpreted as pathogenic. -

not provided Pathogenic:1
Jul 30, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This premature translational stop signal has been observed in individual(s) with clinical features of abetalipoproteinemia (PMID: 8361539). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg595*) in the MTTP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MTTP are known to be pathogenic (PMID: 8533758, 9671739). ClinVar contains an entry for this variant (Variation ID: 14235). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.29
CADD
Pathogenic
39
DANN
Uncertain
1.0
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Benign
0.28
N
Vest4
0.93
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199422219; hg19: chr4-100532313; API